China's manufacturing activity contracted sharply in December for the third month in a row, according to Purchasing Managers' Index (PMI)
The coutry’s PMI came in at 47 points, down from November's 48 and well below the 50-point mark separating growth from contraction, despite China loosening COVID restrictions at the beginning of the month.
For over two years, China had imposed a zero-COVID strategy with strict quarantines, lockdowns, and mass testing that led to unannounced plant closures, disrupted supply chains, and forced permanent company closures.
China abruptly loosened pandemic restrictions on December 7, but the country is still struggling to recover due to a surge in COVID cases.
NBS senior statistician Zhao Qinghe noted that the pandemic has had a significant impact on business production and demand, staff presence, logistics, and distribution.
The index has not been in positive territory since September, and December's figure was lower than the 47.8 reading predicted by Bloomberg analysts.
For its part, the non-manufacturing PMI -- which includes the services and construction sectors -- also contracted further this month, to 41.6 points from 46.7 in November.


Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 



